No date has been set for the long-awaited launch of New Jersey’s recreational cannabis industry, but cannabis officials are already moving for dispensaries to sell a wider array of THC products.
During the Cannabis Regulatory Commission’s meeting Thursday, officials unanimously voted to pass a waiver for medical marijuana providers to produce and sell cannabis concentrates.
Concentrates, which come in the form of dabs, wax, shatter, or oil, are highly potent forms of cannabis that can be ingested or smoked. Thursday’s vote does not affect vape pens, which medical dispensaries can sell now.
Currently, licensed marijuana permit holders can produce marijuana products using flower, oil, or topical forms, and they can provide lozenges. CRC Executive Director Jeff Brown said he’s heard from both industry leaders and patients alike that more people are asking for products in the form of concentrate.
“For a patient who, you know, might want a fast-acting product, who doesn’t want flower, who doesn’t want a vape cartridge, this could provide a very high dose … with one inhalation,” he said.